An in depth look at Oncotarget

Oncotarget is an informational medical based journal which publishes researched based articles pertaining to Oncology. Oncotarget has been in business for seven consecutive years and Impact Journals is responsible for the informative and well researched articles.

Andrew Gudkov is responsible for many of Oncotarget articles, Gudkov has become a major contributor to the success of Oncotarget. In addition, Mr. Gudkov is affiliated with the Roswell Cancer Institute. Therefore, he has first hand knowledge of Cancer, current treatment as well as research involved when searching for new and improved Cancer treatment. Download output styles at Endnote.com.

Oncotarget is considered to be an open access journal which has become increasing popular among medical professionals as well as the general public. Each article published by the company is based upon factual data which is well researched and verified prior to publication. The web site provides information on potential new treatments for Cancer as well as general information on preventative measures and Physician theories concerning the origin of certain Cancers.

Treatment options for Cancer has greatly improved over the years. Newer and less invasive Cancer drugs are in the works. Newer Cancer drugs are geared toward destroying malignant tumors without destroying healthy immune cells within the body. Therefore, Cancer therapy will be less harmful to the internal organs and overall system.

Oncotarget is published two times per week. In addition, it is considered one of the top rated medical information journals within the nation. Thus attracting new readers each and every week. It appears that non-medical professionals have gained a better understanding of Cancer and potential causes and treatment by simply reading Oncotarget’s articles. Read more about Oncotarget at Business Insider.

Oncotarget publishes articles citing certain cases in which a specific Cancer was identified. The articles also publish statistics concerning rate of recovery and cure. Even deadly Cancers now appear to more responsive to treatment which in turn prolongs life and helps patients better cope with their diagnosis.

Read more: http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid

Recent articles published on the Oncotarget web site offer new hope within the area with diseases related Endocrinology as well as diseases which affect the blood and healthy immune cells. Blood diseases can be difficult to treat. However, doctors claim that understanding the complexity of tumor development can help greatly when attempting to properly diagnose and treat potentially fatal Cancers.

Oncotarget welcomes new articles from the medical community. It is important that you follow the important guidelines prior to submission. Currently, the web site is welcoming articles related to Immunology, Cell Death as well as the role Genetics plays in the development of Cancer. Please visit www.impactjournals.com.

Tempur, Cancer, and Eric Lefkofsky

Eric Lefkofsky co-founded Tempus, a data collecting company that aims to improve the treatment of cancer. When his wife became ill with the disease, he realized the oncologist didn’t have all the information on other patients, as he should have had, to properly diagnose the many treatments needed to treat cancer. Tempus was created by Lefkofsky to collect the treatment data of current patients, take all of their personal information off the pertinent data, and send it back to the original source for analysis.

What Mr Lefkofsky would like to see, is an easier route to the research of cancer and the treatments used to cure the disease. People respond differently to the same treatment, and Lefkofsky would like the doctors and other researchers to have the information in front of them, so that they can distinguish one patient from another in terms of treatment. Lefkofsky believes Tempus will be an important tool being used in the discovery of many new personalized vaccines based on gene research, like that of CRISPR. Click here to know more.

Lefkofsky went to the University of Michigan Law and earned his law degree. Soon afterward, in 1994, he and his business partner, Bradley Keywell, borrowed the money to buy, Brandon Apparel. The company did not do well, and lawsuits followed the pair for many years. In 1999, Lefkofsky and Keywell decided to go into business again, this time an internet business that specialized in promotional items called, Starbelly. They sold the business for $240 million. Lefkofsky went on to create, buy, and sell more companies that contributed to his many successes.

Together with his wife, Liz, in 2006, they started the Lefkofsky Family Foundation. Their focus is on the betterment of their community in the Chicago area and globally. The many charities they are involved in include those in the areas of education, health, science, arts and culture, human rights, and Technology.